Preventing Persistent Post- Surgical Pain & Opioid Use in ...€¦ · The development of an integrated treatment for veterans with comorbid chronic pain and posttraumatic stress disorder.
Post on 22-Jul-2020
1 Views
Preview:
Transcript
9/28/2019
1
Preventing Persistent Post-Surgical Pain & Opioid Use in At-
Risk Veterans: Effect of ACT
Katie Hadlandsmyth, PhDUniversity of Iowa, Carver College of Medicine, Iowa City, IA
Barbara St. Marie, PhD, AGPCNP, FAANPUniversity of Iowa, College of Nursing, Iowa City, IA
Midwest Pain Society 43rd Scientific Meeting
Chicago, Illinois
October 4-5, 2019
Disclaimer
Conflicts of Interest/Disclosures
• Hadlandsmyth: Nothing to disclose.
• St. Marie: Receives funding from the National Institute on Drug Abuse (5K23DA043049-03); serves on the Faculty Advisory Panel for CO*RE REMS and is a paid consultant for CO*RE REMS.
1
2
3
9/28/2019
2
Objectives
1. To appraise the value of an Acceptance and Commitment Therapy (ACT) workshop among patients undergoing orthopedic surgeries.
2. To differentiate the contribution of mixed methods to this study on (ACT).
3. To understand barriers and facilitators of implementing ACT for patients preparing for surgery.
Acknowledgements• Co-PIs: Barb Rakel, RN, PhD; Lillian Dindo, PhD• Investigators:
• Toni Tripp-Reimer, RN, PhD, FAAN• Barbara St. Marie, RN, PhD• M. Bridget Zimmerman, PhD (Stat)• Jim Marchman, PhD• Nicholas Noiseux, MD
• Personnel:• Katie Hadlandsmyth, Project Director• Jennie Embree, Data Manager• Katie Geasland, Blinded Research Assistant• Judy Allen, Qualitative Analyst• Edin Sabic/Roohina Wajid, Research Interns• Clevenger, Van Liew, Grekin, Kroska (Psych Grad RAs)• Benjamin, Benschoter, Eschar (BSN Students)
Background/Rationale
• Rates of persistent post-surgical pain:
• 50-85% amputations
• 50% Thoracotomy
• 20% Total Knee Arthroplasty
• 20-50% breast surgeries
(Correll, 2017)
• Distress-based conditions put patients at risk for persistent pain and prolonged opioid use following surgery (Otis, Keane, Kerns et al., 2009; Kerns, Otis, Rosenberg et al., 2003).
• Preventing these problems for the thousands of patients who undergo surgery each year can have a dramatic impact on quality of life, productivity, and reduced risk of life-threatening issues, such as opioid misuse and suicidal ideation.
4
5
6
9/28/2019
3
• ACT reduces pain, depression/anxiety.
• Pre-surgery predictors of persistent pain 6 months post TKR.
• ROM pain (p=0.0005),
• Anxiety (p=0.02),
• Depression (p=0.05)
Logic Model
Dindo et al, 2014Noiseux et al, 2014
Study Aims
Primary Aim #1: Determine the feasibility of providing a 1-day ACT workshop and individualized booster session with at-risk veterans before and after surgery.
Primary Aim #2: Determine if an ACT workshop & booster reduces the length and/or amount of pain and opioid use following surgery when compared to TAU.
• Mixed Methods• Guided open-ended interviews
• Single-blinded, prospective, randomized, experimental design with random assignment to one of two groups:
1. Treatment As Usual (TAU)
2. Acceptance and Commitment Therapy (ACT) plus TAU (ACT + TAU)
• Iowa City VAMC – orthopedic surgery clinic• Serves over 184,000 veterans living in 50 counties in Eastern Iowa, Western Illinois
and Northern Missouri.
• Tri-level care system; primary, secondary, and tertiary care to patients requiring orthopedic surgery.
Design/Setting
7
8
9
9/28/2019
4
• Inclusion Criteria:• Veterans, ≥ 18 years old, scheduled for orthopedic surgery• Identified to be “at-risk” at screening visit:
• Preoperative Pain (movement) > 7 OR > 3 and
• HAM-A (anxiety) ≥15 or
• HAMD (depression) ≥17
• Exclusion Criteria:• Mental incapacity or a language barrier• History of brain injury• Bipolar or psychotic disorder• Complications following surgery requiring reoperation
• Sample Size:• 70% power at p < 0.05, a 50% reduction in median time to pain or opioid cessation OR hazard ratio
for quitting of 2.0.
Participants
Methods
Inclusion Criteria Not Met (n=221)
Surgery timing/surgery not scheduled (n=195)Absent anxiety/depression/pain (n=26)
Excluded (n=40)Bipolar, psychotic disorder (n=24)
Cognitive disorder, dementia, brain injury (n=13)Non-English speaking (n=1)
Malingering, suicidal ideation (n=2)Declined (n=187)
Unable to contact (n=92)
Enrollment Assessed for eligibility (indicated for eligible surgery) (n=628)
Randomized (n=88)
CONSORT Diagram
Allocated to ACT (n=44)
Received Surgery and Attended Workshop (n=32)Received Surgery and Did Not Attend Workshop (n=8)
Surgery Cancelled, Attended Workshop, (n=2)Surgery Cancelled, Did Not Attend Workshop (n=2)
Allocated to TAU (n=44)
Received Surgery (n=36)Surgery Cancelled (n=8)
Allocation
Lost to follow-up (n=0)
Excluded due to AE (n=1)Lost to follow-up (n=0)
Excluded due to low pain at enrollment (n=1)
Follow-Up
Intent-to-treat analysis (n=35)
Protocol analysis (n=35)
Intent-to-treat analysis (n=40)
Protocol analysis (n=31)
Analysis
Not interested (n=87)
Too busy (n=58)Trav el difficulties (n=36)Other (n=6)
Workshop mentioned as a factor (n=28)
10
11
12
9/28/2019
5
Sample Characteristics
0
2
4
6
8
10
ACT TAU
Average of BPI Measures at Enrollment
BPI Least BPI Ave BPI Worst
0%
10%
20%
30%
40%
50%
60%
70%
ACT TAU Total
Subjects above Cut-offs
Anxiety ≥ 15 Depression ≥ 17 Max ROM Pain ≥7
• Workshop – 34/44 (77%) attended a workshop
• 1st scheduling attempt: 26 (76%)
• 2nd attempt : 6 (18%)
• 3rd attempt : 2 (6%)
• Never attended: 10/44 (20%) • Health-4; Work-2; Caregiving-2; Unspecified-2
• Booster received – 29/32 (91%) following surgery
• 4 Feasibility Issues: 1) Workshop logistics; 2) Workshop size; 3) Workshop Content and Structure; 4) Use of Manual and Booster Session.
Aim 1: Feasibility
0 1 2 3 4 5 6 7
Unspecific
Vacation
Caregiver Needs
Lost
Surgery Timing
Travel Difficulties
Medical Appt
Sick
Work
Barriers to Scheduling Workshop
St. Marie et al (in progress)
Aim 2: Potential Efficacy
Pain > 3
Opioid Use
Dindo et al (2018). J Pain
13
14
15
9/28/2019
6
Aim 2: Mediation by CPAQ and CPVI
Dindo et al (2018). J Pain
Pain >3
Opioid Use
Qualitative Research
• Qualitative purpose• Examined ACT skills reported used a 1 week following workshop and 3
months after surgery
• Map the skills to the theoretical constructs of ACT
• Prospective, longitudinal data
• Data collection• Phone interviews at 1 week and 3 months lasting 20-40 minutes
• Semi-structured interview guide
• Two qualitative researchers and a research assistant
• Content analysis – Nvivo®
Results: Feasibility
• Barriers• Description of ACT and what it does
• Travel difficulties – Rural, Winter
• Scheduling conflicts – other medical appointments, pre-operative timeframe
• Workshop size – 2-3 participants
• Facilitators• Group format
• Engaging content and trainers
• Use of manual and booster session
16
17
18
9/28/2019
7
Mapping skills to ACT theoretical constructsOpenness Awareness Engagement
ACT processes Acceptance Cognitive defusion Present moment Self as context Values Committed action
Participants’Skills Themes
• Acceptance• Acknowledge feelings
• New approach to thinking
• Mindful breathing
• Focus on now
• Self-awareness • Re-prioritizing• Choice awareness
• Setting goals• Choice awareness
Openness
Acceptance Cognitive defusion
Acceptance
Acknowledge feelings
New approach to thinking
One participant stated he was “… accepting maybe some of the pain, … then still carrying
on with my life” rather than focusing on things he could not do.
“What I took home from that [workshop] … is how to distance myself from – it helps out with
my depression and everything ‘cuz I get frustrated a lot, … It’s taking too long to heal… Instead of internalizing all of that into myself,
and just thinking ‘I’m no good,’ and ‘It’s my fault that this isn’t working…’ It helped me step outside of the box and look at it in a different
direction.”
Awareness
Present moment
Self as context
Mindful breathing
Focus on now
Self-awareness
“… if I live in the now, I’m not regurgitating all the pain from yesterday and I’m not stressing myself out on what
might be tomorrow.”
“[now he was] just trying to be aware of the pain, and that it’s gonna get better…
Since then, I’m really getting’ around great, doin’ a lot of walkin’, and a lot of
talkin’ to people. Before [the workshop], I was at home and not doin’ much and
bein’ angry.”
19
20
21
9/28/2019
8
“…relate to your family and your kids, and what’s important to you. You what’s important to you, but you just don’t think about it in certain ways. That [ACT workshop] made you think about it a little different way.”
Choices after this surgery compared to previous surgery:“I don’t need the tramadol so much.”Previously he thought pain was “boss” and now he chooses to not allow pain to stop the valued life, and to relax with the pain.
EngagementValues Committed
actionRe-prioritizing
Choice awareness
Setting goals
Choice awareness
Sustained goals
• Understanding and clarifying about what’s important
• Build goals around these important values
• One participant stated well:• First interview – set his goals to be more active, to engage in something, and
to re-establish good health• Three months later – still kept his goals, continued his rehabilitation on his
own.
• Another participant stated before the workshop or the surgery, pain created a “… constant battle of whether I wanted to get up and move around, or not.”
• Their goals helped to reduce impediment created by pain.
Conclusion
• Findings from this pilot feasibility study indicate:• Potential efficacy
• Feasibility with some modifications
• Qualitative findings: Participants seemed to understood the ACT model of engaging in values-based living even in the presence of aversive internal content (such as pain).
• Next Steps: Larger multi-site RCT
22
23
24
9/28/2019
9
References
1. Noiseux, N.O., et al., Preoperative predictors of pain following total knee arthroplasty. J Arthroplasty, 2014. 29(7): p. 1383-7.
2. Otis , J.D., Keane, T.M., Kerns, R.D., Monson, C., Scioli, E. (2009). The development of an integrated treatment for veterans with comorbid chronic pain and posttraumatic stress disorder. Pain Medicine, 10,1300-1311.
3. Kerns, R.D., Otis, J, Rosenberg, R., Reid, M.C. (2003). Veterans’ reports of pain and associations with ratings of health, health-risk behaviors, affective distress, and use of the healthcare system. Journal of Rehabilitation Research Development, 40,371-379.
4. Rakel, B.S., Glodgett, N.P., Zimmerman, B.M., et al. (2012). Predictors of postoperative movement and resting pain following total knee replacement. Pain, 153,2192-2203.
5. Lamberts, M.P., Lugtenberg, M., Rovers, M.M. et al. (2013). Persistent and de novo symptoms after cholecystectomy: a systematic review of cholecystectomy effectiveness. Surgical Endoscopy, 27, 709-718,
6. Puolakka, P.A., Rorarius, M.G., Robiola, M., Puolakka, T.J., Nordhausen, K., Lindgren, L. (2010). Persistent pain following knee arthroplasty. European Journal of Anaesthesiology, 27,455-460.
7. Dindo, L., et al., One-day behavioral intervention in depressed migraine patients: effects on headache. Headache, 2014. 54(3): p. 528-38.
8. Dindo et al (2018). Acceptance and Commitment Therapy for Prevention of Chronic Post-surgical Pain and Opioid Use in At-Risk Veterans: A Pilot Randomized Controlled Study. J Pain, May 16. [Epub ahead of print]
9. Hayes, S.C., Luoma, J.B., Bond, F.W., Masuda, A., Lillis, J. (2006). Acceptance and commitment therapy: Model, processes and outcomes. Behaviour Research and Therapy, 44,1-25.
10. Hayes, S.C., Vallatte, M., Levin, M., Hildebrandt, M. (2011). Open, aware, and active: Contextual approaches as an emerging trend in the behavioral and cognitive therapies. Annual Review of Clinical Psychology, 7,14—168.
11. McCracken, L.M., Vowles, K.E. (2008). A prospective analysis of acceptance of pain and values-based action in patients with chronic pain. Health Psychology, 27,215-220/.
12. Vowles , K.E., McCracken, L.M., Zhao O’Brien, J. (2011). Acceptance and values-based action in chronic pain: a three-year follow-up analysis of treatment effectiveness and process. Behaviour Research and Therapy, 49,748-755.
Self-Assessment Questions
1. What outcome(s) did this intervention have a positive impact on?
a) Reduction of opioids use following surgery
b) Improvement of pain following surgery
c) A and B
d) None of the above
Self-Assessment Questions
1. What outcome(s) did this intervention have a positive impact on?a) Reduction of opioids use following surgery
b) Improvement of pain following surgery
c) A and B
d) None of the above
25
26
27
9/28/2019
10
Self-Assessment Questions
2. Select outcome that was confirmed by both qualitative and quantitative data analysis.
a) Improve ability to communicate feelings
b) Improve function and return to activities
c) Use of values-based activities
d) All of the above
Self-Assessment Questions
2. Select outcome that was confirmed by both qualitative and quantitative data analysis.
a) Improve ability to communicate feelings
b) Improve function and return to activities
c) Use of values-based activities
d) All of the above
Self-Assessment Questions
3. Select one barrier to providing ACT in a perioperative time frame.a) Timing of surgery
b) Patient readiness for surgery
c) Location of ACT training
d) All the above
28
29
30
9/28/2019
11
Self-Assessment Questions
3. Select one barrier to providing ACT in a perioperative time frame.a) Timing of surgery
b) Patient readiness for surgery
c) Location of ACT training
d) All the above
Self-Assessment Questions
4. What are indicators that a 1-day ACT workshop is feasible among Veterans
a) Participants completed the workshop
b) 1-day ACT workshops have been successful in other populations
c) A and B
d) None of the above
Self-Assessment Questions
4. What are indicators that a 1-day ACT workshop is feasible among Veterans
a) Participants completed the workshop
b) 1-day ACT workshops have been successful in other populations
c) A and B
d) None of the above
31
32
33
9/28/2019
12
The Dynamics of Managing Acute Postoperative Pain in the Current Opioid Sparing Environment
Robert L. Barkin, MBA, Pharm D, DAAPM, DACFE, OFRSM
Midwest Pain Society 43rd Scientific Meeting
Chicago, Illinois
October 4-5, 2019
Summary statements regarding postoperative pain Rx with a focus on the impact of scheduled analgesics versus no scheduled analgesics related to the management of in-hospital acute postoperative pain management
Robert L. Barkin, MBA, Pharm D, FCP, DAAPM, DACFE, OFRSM, Professor (Anesthesiology, Family Medicine, Pharmacology) Rush Medical College of Rush University (Chicago, IL); Clinical Pharmacologist, Department of Anesthesiology NorthShore University HealthSystem, Pain Centers The Orthopedic and Spinal Institute at Evanston & Skokie Hospitals Illinois
Disclaimer
34
35
36
9/28/2019
13
Conflicts of Interest/Disclosures
• Nothing material to disclose on this subject
Objectives
1. Explain how to create a patient-specific, structured, time contingent postoperative hospital pain management plan
2. Discriminate established medical diagnosis vs. testimonial and catastrophizing
3. Explain how to integrate patient family collateral HCP in facilitating treatment initiation and pursuit of therapeutic benefit
▪Initially: PMHx, PSHx, PΨHx, social Hx, Rx Hx (Rx, OTC, phytopharmacueticals), “Allergies v. S/E’s,” PPMP, (multisource medications), OLD Rxs, friends, spouses, internet, external to USA travel, laboratory, EKG evaluation, (QTc)
• Pt (spouse, family), age, experiences, fears, education, expectations, post- op and pre-op opioid consumption and Pt unique needs.
• Multimodal pharmacotherapy, scheduled structure, overlapping intervals, PRN’s for BTP to decrease higher doses of scheduled opioids, comorbid painful syndrome/DX (often patient amalgamated), neuroaxial opioids, ESI, IT routes.
37
38
39
9/28/2019
14
▪ Timely pre-surgical discussion in joint collaboration with patient, concerned others, collateral providers and the surgical team, structured decremental changes (opioid naïve v. tolerant). Create a patient-specific, patient focused, patient centered, personalized time contingent Rx plan accepted fully by patient and concerned others.
▪ Pathways: transmission, transduction/conduction, perception, modulation
▪ Scheduled analgesia v. anesthesia
▪ Focus: diminish pain and suffering in quality and quantity through scheduled analgesic Rx plan with PRN for BTP and episodes. Diminish fear/anxiety of pain and improve postop functionality, ADLs, PT/OT performance; personal past experience and preferences; diminish pharmacotherapy iatrogenic effects, etc. (constipation, GU, CNS, neuro, pulmonary, cardiac events); Address: nociceptive, neuropathic pain, collateral comorbid pains, reduce, LOS facilitated by initiating a structured time contingent scheduled dosage regimen.
▪ Negotiate catastrophizing cognitive distortion as an exaggeration, magnification or irrational thought pattern. A triad of rumination, magnification, helplessness.
▪ Addressing these focused events. “Predict and control.”
▪Pharmacotherapy: (time contingent structured Rx plan with an exit strategy for BTP)
APAP (IV, PO)
NSAIDS (ketorolac IV, PO NSAIDS), w/ or w/o anesthetics
AD – SNRI
SMR – Tizanidine, Orphenadrine, baclofen
AED – Gabapentinoids, (avoid for foot/ankles surgery), topiramate
NMDA: ketamine (IV), Subdissociative-dose (0.25 to 0.5mg/kg) MG++, N20, DM., Orphenadrine, Memantine, Meperidine, Levorphanal, Methadone Tramadol
Opioids: PO, Buccal, IV schedule doses, with limited short acting for BTP.
Anesthetics: Na+ channel blockers IV (short or long acting), topical
Tx plan exit strategy: 5 to 7 days up to 21 days (a function of extensiveness procedures, simulate home discharge environments routine (ECF/NH)
▪Time contingent plan (arise, asleep), nocturnia, periods of antecedent pain.
▪ Insurance/PBM coordination.
▪Time schedule for detrimental change to lowest effective dose to participate in home; patient without precipitating abstinence or withdrawal behavior
▪Stop all former historical opioid pain medications once at home or before Tx initiation in conjunction with pre-surgical evaluation plan.
▪Surgical team to maintain bilateral open dialogue with patient/family/care givers following hospital discharge with Pain Center staff as consultation.
40
41
42
9/28/2019
15
Case 1
▪1) A 49 y/o male 73” H, 270#, BMI=33 presents for TKR due to sports trauma injury
▪Vocation: MBA, JD, CPA, CEO of 180 person firm.
▪Avocation: Runner, basketball, biking, gym, golf weekends
▪Pain 4-10/10 a function of movement, comfortable with 4/10, achy, dull, neuropathic, nociceptive, if with pharmacotherapies present.
▪PMHx: Migraine, hyperchol, GERD, OSA (CPAP – non-compliant)
▪PSHx: Abd. hernia (repair - wt. lifting), clavicle repair from sports injury, ankle FX (repair, running)
▪Allergies: NKDA, FA, EA, No RX side effects reported
Case 1 (Cont)
▪ SOC Hx: Married, 2 children, ETOH (states 1.5 oz whisky/ day 7d/wk) Spouse reveals an amount in excess of this. (must stop), nicotine Hx (cigars 1/day 7/week) (must stop), cannabis (weekend 1/d), SRDU – denies
▪ PΨHx – denies; DIMS (sleep 11pm 3A/d).
▪ Note: Spouse and pt describe on cellphone and laptop “all the time”, confirmed by house staff & nursing, OT/PT
▪ OTC: Ibuprofen (2 to 3 200mg Ø 6 hr PRN, not daily), DPH- to stop use.
▪ Herbals: Melatonin
▪ PPMP: Hydrocodone and Oxycodone alternates monthly with 2 different prescribers with different practices, not jointly aware
▪ Labs: WNL, Cr.8, LFT’s WNL, CUDT: (+1 oxycodone, hydrocodone, cannabis)
▪ Test: QTc 412, EKG = NSR
▪ INPT TX plan: PT/OT Pharmacotherapy to transfer to ECF for PT/OT in 2 days.
Case 1 (Cont)
▪Pt “needs”: Expressed: “I do not want to ask for medications or “buzz” the nurses for it”, discussed structured time component to plan and rational.
▪Plan: 1) schedule Rx plan in full
2) schedule the Tx plan with plans for BTP
3) use PRN to evaluate needs for outpatient ECF/N.H., P.T.
4) use PRNs and request pt. to F/u with one PCP for opioids if needed for functionality with whom he has a fiduciary relationship.
5) CPM of presurgery and add gabapentinoids and SMRs, opioids 5-7 days (consult w/ surgery team) a function of extent of surgery.
43
44
45
9/28/2019
16
Case 2
▪A 61 y/o female, 64” 192# BMI=33
▪S/P (R) Hip Fx due to fall at home while doing housework
▪Pain 8-9/10 dull, achy, throbbing, stabbing, 10/10 with movement
▪PMHx: osteoporosis hypercholesterolemia, DM (type 2, diet) FMS, IBS
▪PSHx: breast Bx(-), TAH, Appy
▪Allergies/ S/E’s 6-keto opioids = CNS, neuro, CV hyportension, GU, GI events
▪PΨHX: denies; aside DIMS, tearful about this fall, feels hopeless, helpless, loss of self esteem.
▪SOCHx: Solitary living, EtoH (6 oz. wine/noc) nicotine: Ø, cannabis: Ø, SRDU: Ø, has one cat
▪PPMP: reviewed=WNL
Case 2 (Cont)
▪Routine: arise 6am, asleep 10pm, nocturie once
▪RxHx: Stating (use every other day), oral hypoglycemic (less than compliant)
▪OTC: D3, APAP, NSAIDS (not sure of doses or names of drugs)
▪Herbals: garlic, ginger, ginseng (to stop), turmeric, melatonin
▪Labs: CMP-WNL
▪Tests: EKG=NSR, QTc=410
▪Note: Resistance to medication “use reflects weakness” Has teenage grandchildren who visit
Case 2 (Cont)
▪Plan: 1) Stop all home use OTC/Rx for pain
2) Stop herbals-rationale given
3) Opioids LA Q 8 to 12 hrs (abuse deterrent)
4) APAP 500mg Q 8 hr PRN pain
5) Small dose short acting opioids Q 8hr PRN for BTP
6) Inpt small dose IV opioids for pain which is unresponsive to above Tx
7) SNRI for pain, FMS, tearfulness (have social worker see pt)
8) Low dose gabapentinoids, or topiramate
10) scheduled NSAID IV of 6 hours when appropriate
46
47
48
9/28/2019
17
Case 2 (Cont)
▪Choices: 1) PRN doses only
2) Timed doses of Rx plan, stop herbal/OTC at home
3) Scheduled Tx plan with PRN (for BTP)
4) Refer back to PCP within 15 days of outpatient post OP pain meds
Pharmacotherapeutic Rapid Evaluation (per RLB)▪Efficacy v. Efficiency
▪2. Iatrogenic Effects v. Toxic Effects
▪3. Compliance/Adherence v. Nonadherence
▪4. Economics (Payor, Self, Copay, PBM)
▪5. Monitoring; who, what, why, where
▪6. Outcomes
▪7. “Communicate before you medicate” (RLB)
▪8. Noncompliances or Noncomplainers (J. Clin Psychiatry 1988, Barkin, Stein)
Proposal for Opioid Free Anesthesia (Intraoperative Pain)• Perioperative: APAP, NSAID (w/o C/I), scopolamine patch.
• Intraoperative: Multimodal Opioid sparing systemic analgesia, regional anesthesia evaluation, epidural anesthesia, intrathecal route.
• Ketorolac, clonidine, lidocaine/bupivacaine, gabapentinoids, ketamine. MgSO4, methylprednisolone (Can J. Anesth 2003 50:336-41)
• Dexmedetomidine (Br J Anesth 2014 112:906-11) or N20, propofol, SMR.
• Postoperative: Monitor for analgesic needs, medication side effects, medication therapeutic effects or a potential iatrogenic ADRs.
• CPM above, anti-hyperalgesic if perceived prominent nocicption persists-consider anesthesiologists fellowship trained pain specialist with a multidisciplinary pain management team inpatient and outpatient.
49
50
51
9/28/2019
18
Self-Assessment Questions
1. In the process of designing a patient specific treatment for postoperative pain which process below is/are most important?a) Transmissionb) Conductionc) Perceptiond) Modulatione) All of the above
Self-Assessment Questions
1. In the process of designing a patient specific treatment for postoperative pain which process below is/are most important?a) Transmissionb) Conductionc) Perceptiond) Modulatione) All of the above
Self-Assessment Questions
2. During the process of synthesizing a comprehensive
treatment which of the following is/are most important?a) Incorporating a patient specific treatment planb) Encourage involvement of direct family care-givers
facilitating therapeutic benefitsc) Engage the collateral health care providers insightsd) All of the above
52
53
54
9/28/2019
19
Self-Assessment Questions
2. During the process of synthesizing a comprehensive
treatment which of the following is/are most important?a) Incorporating a patient specific treatment planb) Encourage involvement of direct family care-givers
facilitating therapeutic benefitsc) Engage the collateral health care providers insightsd) All of the above
Self-Assessment Questions
3. During an evaluation of the following receiving
phenomena, identify the most significant to utilizea) Medical diagnosis confirmed in the recordb) Patient/family testimonialsc) Catastrophizingd) Patient medication demandse) All of the above
Self-Assessment Questions
3. During an evaluation of the following receiving
phenomena, identify the most significant to utilizea) Medical diagnosis confirmed in the recordb) Patient/family testimonialsc) Catastrophizingd) Patient medication demandse) All of the above
55
56
57
9/28/2019
20
Creating and Implementing Enhanced Recovery After Surgery (ERAS) Programs
Rebecca N. Blumenthal, MD
Vice Chair of Innovation
Department of Anesthesiology, Cri tica l Care and Pain Medicine
NorthShore University HealthSystem
Cl inical Assistant Professor
Univers ity of Chicago, Pri tzker School of Medicine
Disclosures
59
• Describe the most common components of ERAS protocols, and discuss the history and evidence-based practice of enhanced recovery
• Demonstrate that ERAS protocols provide transformative plans for minimizing pain, reducing perioperative opioid usage, expediting patient recovery, and decreasing perioperative complications
• Outline the process for creation of ERAS programs for hospital systems, and identify some limitations and challenges for successful ERAS design and implementation
Learning Objectives
60
58
59
60
9/28/2019
21
Creating and Implementing Enhanced Recovery Programs
Increase Awareness and “Buy-In”
Increase Awareness and “Buy-In”
Develop PlanDevelop PlanAssemble Multi-
disciplinary TeamAssemble Multi-
disciplinary TeamPrepare and
Execute RolloutPrepare and
Execute RolloutEnsure Sustainable
ModelEnsure Sustainable
Model
61
Creating and Implementing Enhanced Recovery Programs
Increase
Awareness and
“Buy-In”
Increase
Awareness and
“Buy-In”
Develop PlanDevelop Plan
Assemble Multi-
disciplinary
Team
Assemble Multi-
disciplinary
Team
Prepare and
Execute Rollout
Prepare and
Execute Rollout
Ensure
Sustainable
Model
Ensure
Sustainable
Model
62
• Enhanced Recovery After Surgery
• Proven multidisciplinary, collaborative approach
• Scientific principles used to optimize pre-, intra-, and post-operative care
• ERAS protocols have been shown to:
oDecrease length of stay (LOS)
oDecrease perioperative complicationso Improve outcomes
oLower cost
ERAS: Definition
63
61
62
63
9/28/2019
22
• Average LOS for elective colorectal surgery was 6-12 days.
• Advances in laparoscopic surgery decreased LOS to 4-6 days.
1990s
• Kehlet et al (Denmark) did multi-modal rehab and decreased LOS to 2 days.
• 3 Interventions.
2000• “ERAS was born.”
• Intent: Develop evidence-based perioperative care pathways to facilitate patient recovery.
2001
History of ERAS
64
• ERAS pathways proliferated nationally and internationally, initially for colorectal, but then developed for other surgical sub-specialties
• Multiple conclusive studies proved the efficacy of each step of the protocols
• Preponderance of clinical outcomes literature for ERAS versus conventional care supports:
oReduced surgical stress
o Improved recovery of GI function
oFewer complications
oDecreased LOS with no increase in readmissions
ERAS in the 21st Century
65
Goals of an ERAS Protocol
Deliver Comprehensive Perioperative Care that is
Patient-Centered and Reduces Variation in
Outcomes
Optimize Patients for Surgery, Minimize Stress,
and Restore Normal Physiology Expeditiously
Encourage Clinician Teamw ork and
Communication to Achieve Process Measure
Compliance and Success
66
64
65
66
9/28/2019
23
PREOPERATIVE
-Preoperative Education and Optimization (Prehabilitation)
-Preoperative Fasting Guidelines and Carbohydrate Loading
-El imination of Mechanical Bowel Preps
-Thromboembolism and Antimicrobial Prophylaxis
INTRAOPERATIVE
-Multimodal Non-Opioid Analgesics and Antiemetics
-Regional Anesthesia
-Normothermia and Euvolemia
-Minimize and Early Removal of Dra ins/Foleys/NGs
POSTOPERATIVE
-Early Mobi l ization/Ambulation
-Early Nutri tion
-Multimodal Non-Opioid Analgesics
Components of an Enhanced Recovery Program
67
• Preoperative Period thru Post Discharge/Recovery
• Use Combinations of Non-Opioid Analgesics
• Improve Pain Scores
• Decrease Opioid Related Side Effects and LOS
oNausea/Vomiting and Pruritus
o Sedation and Respiratory Depression
o Ileus and Urinary Retention
o Post-op Delirium and Addiction
• Greater Patient Satisfaction
Multimodal Non-Opioid Analgesics
68
DECREASE OPIOID USE DECREASE PAIN DECREASE PONV OTHER
TYLENOL Yes Yes Yes Synergy with NSAIDS
NSAIDS Yes Yes YesSide Effects: COX-1 versus COX-2
GABAPENTIN Yes Yes Yes Sedation
LIDOCAINE Yes Yes NoQuick Return of GI Function
KETAMINE Yes Yes Yes Bolus vs. Infusion
Common ERAS Multimodal Non-Opioid Analgesics
Other Analgesics: Alpha-2 Agonists, Steroids, B-Blockers, Magnesium, Non-Pharmacologic
Sources: Beverly et al. (2017), Helander et al., (2017), Khan et al. (2016), Wang et al. (2016), DeOliveria et al. (2015),Tan et al., (2015), Apfel et al. (2013), Schmidt et al. (2013), McNicol et al. (2011), Ong et al. (2010), Hurley et al. (2006), and Straube et al. (2005)
69
67
68
69
9/28/2019
24
1 Multimodal Analgesic
2 Multimodal Analgesics
>2 Multimodal Analgesics
“Stepwise” Positive Effects of Multimodals
Additions of Non-Opioid Analgesics Associated with Additive Positive Effects in Total Joints.
>2 Multimodals:1. 19% Decreased Resp. Compl.
2. 26% Decreased GI Compl.3. 18.5% Decreased Opioid Usage4. 12.1% Decreased LOS
NSAIDS and Cox-2 Inhibitors were the MOST EFFECTIVE Multimodal Non-Opioid Analgesics
Source: Memtsoudis et al. (2018)
70
Peripheral Neural Blockade (e.g. TAP, Upper and Lower Extremity
Blocks)
Decrease Opioid Consumption
Decrease LOS (about 1 day)
Decrease PONV and Post-Op Ileus
Excellent for Laparoscopic Abdominal and Ortho Procedures
Central Neural Blockade (e.g. Epidural and SAB)
Decrease Time to Return of Gut Function (by 17 hours)
Decrease Opioids and Post-op Morbidity (CV, Pulm, GI)
Decrease LOS (about 1 day)
Decrease Protein Catabolism and Endocrine Metabolic Response
Excellent in Open Abdominal Procedures
Use Low Concentration of Local Anesthetic to Prevent Motor Block and Hypotension
Regional Anesthesia
Sources: Pirrera et al. (2018), Helander et al. (2017), Kim et al. (2017), Guay et al. (2016), Popping et al. (2014), Favuzza et al. (2013), Johns et al. (2012), Charlton et al. (2010), and Holte et al. (2002)
71
Rogers et al. (2018) Braga et al. (2018) Aarts et al. (2018) Pecorelli et al. (2017)
VATS; 422 pts Colorectal; 722 pts Colorectal; 2876 pts Colorectal; 347 pts
Protocol Compliance Protocol Compliance Protocol Compliance
Early Mobilization Early Mobilization Early Mobilization
Early Nutrition Early Nutrition Early Nutrition
Early Removal of Drains/Tubes Early Removal of Drains/Tubes
Preop Carbohydrate Drinks Delete Mechanical Bowel Prep, Normothermia
Laparoscopy
ERAS Elements with Greatest Impact on Recovery
ERAS elements with the greatest impact
72
70
71
72
9/28/2019
25
Improve Patient Education and Participation
Optimize Perioperative Nutrition
Standardize Perioperative Anesthetic Regimens
Minimize Pain/Opioid Usage/Stress Response
Encourage Early Mobilization and Oral Intake
ERAS Protocols are Evidence-Based
73
Nicholson et al., 2014, BJSLau et al., 2017,
World J SurgVisioni et al., 2017, Annals of
Surg
# Randomized Controlled Studies 38 42 39
# Patients 5,099 5,241 6,500
Surgical Sub-SpecialtiesCR, GU, Ortho, Upper GI,
ThoracicCR, GU, Ortho, Upper GI, Thoracic CR, GU, Upper GI
Decreased LOS 1.14 days 2.35 days 2.50 days
Decreased Complications 30% 38% Odds Ratio=0.7
Decreased Cost N/A $830-$3100/day $5109
No changes in…Mortality, Readmissions, Major
ComplMortality, Readmissions (except
upper GI)Readmissions
Meta-Analysis of ERAS Programs in Surgical Patients
74
Cost
• Reduced Cost
• Increased Revenue
Infection
• Reduced Post-op Infections
• Decreased Inflammatory Mediators
Opioids
• Reduced Opioid Usage
• Decreased Addiction Risk
Cancer
• Rapid Recovery and Return to Oncologic Therapy
• Decreased Cancer Recurrence and Improved QOL
Additional ERAS Benefits
75
73
74
75
9/28/2019
26
• Health Economics in ERAS Programs
(Stowers et al., Can J Anesth 2015)
o 17 Studies
o Colorectal, Bariatric, Gyne, Gastric, Pancreatic, Esophageal, Vascular
o All Studies Report Cost Savings (Related to Quick Recovery, Decreased Morbidity and Complications)
o All Costs are In-Hospital Costs
o Few Studies Account for Readmissions and Follow-Up
• ERAS protocols need initial investments by institutions, but rapidly result in important gains financially and clinically
• Once implemented, financial gains continue to result in considerable savings proportional to the number of patients in the protocols
Cost Benefits
76
36 Abdominal and Pelvic Surgical
Studies, 4142 pts (2070 ERAS, 2072
non-ERAS)
ERAS Decreases
LOS
ERASReduces Post-op SSI, UTI,
Pulm. Compl.
ERAS Decreases
PeriopInflamm. (CRP,IL-6)
ERAS Improves Post-op Immune Function
ERAS Protocols Reduce Post-op Infections
Rational For ERAS Benefit:1. Preincision Abx, Surg. Site Antiseptic Prep2. Nutrition (Pre-op Carbs, Early Enteral PO)3. Laparoscopy4. Normothermia5. GDFT6. Early Removal of Drains, Tubes, Catheters
Source: Grant et al. (2017)
77
• US Opioid Epidemic
o 2 million Americans dependent on opioids for chronic medical conditions
o >4 million Americans use prescription opioids non-medically
o 1/3 of people addicted to opioids took their first opioid
post-operatively
o 2018-DEA mandated a 20% decrease in opioid manufacturing
• ERAS Solution-Decrease Perioperative Opioid Usage
o Patient Education and Expectation Management
o Multimodal Non-Opioid Analgesia
o Regional Anesthesia
• Challenge: Define Appropriate Quantity of Post-op Discharge Meds
ERAS Protocols Combat the Opioid Crisis
78
Sources: Brandal et al. (2017), Warren et al. (2017), Wick et al. (2017)
76
77
78
9/28/2019
27
ERAS Impacts Cancer Survival
79
Sources: Asklid et al. (2017), Kim et al. (2016), Juneja et al. (2014), Gustafsson et al. (2013)
Creating and Implementing Enhanced Recovery Programs
Increase Awareness
and “Buy-In”
Increase Awareness
and “Buy-In”Develop PlanDevelop Plan
Assemble Multi-
disciplinary Team
Assemble Multi-
disciplinary Team
Prepare and
Execute Rollout
Prepare and
Execute Rollout
Ensure Sustainable
Model
Ensure Sustainable
Model
80
How Do We Implement ERAS Pathways???
• There is No Formula!
• ERAS Must be Tailored to an Institution and Practice.
• Coordination, Integration, and Standardization are Keys for Successful ERAS Programs.
81
79
80
81
9/28/2019
28
First Steps of ERAS Implementation
Review Quality Data
Quantifiable Data Describing the Current State for a Specific SurgicalSpecialty, i.e. Volume, Growth, Adverse Event Risk
Define Metrics to Improve
Realistic Goals Identified to Achieve eg. LOS, opioid usage, complication rate, readmission rate etc.
Identify ERAS “Champion”
Typically a Physician (Anesthesiologist or Surgeon) Willing to LeadERAS Design and Implementation with a Multidisciplinary Team
82
Appoint a Clinical “Champion”
83
Champion’s Initial Responsibilites
Administrative
Support
1. Awarenessand “Buy-In”2. Financial Backing3. Resource Availability
Literature
Review
1. Evidence Based Practice2. Current Literature Review-ERAS Society Recs3. Reputable/Comparable Institution Model
Goals and
Outline
1. Use Quality Data2. Identify First Surgical Service3. Define InitialTimeline
Recruit Motivated
Leaders
1. Surgery/Anesthesiology2. Quality3. Nursing etc.
84
82
83
84
9/28/2019
29
Creating and Implementing Enhanced Recovery Programs
Increase Awareness
and ”Buy-In”
Increase Awareness
and ”Buy-In”Develop PlanDevelop Plan
Assemble Multi-
disciplinary Team
Assemble Multi-
disciplinary Team
Prepare and
Execute Rollout
Prepare and
Execute Rollout
Ensure Sustainable
Model
Ensure Sustainable
Model
85
Anesthesiology
Surgery
Quality Managers
Nursing
Pharmacy
Phys ical Therapy
Pain Clinic
Nutri tion
Information Technology-EMR
Home Care
Multidisciplinary Team of Stakeholders
86
ERAS Steering Group Meetings
87
ERAS Steering Group Meetings
• Start with Core Group
• Present Quality Data• Build Consensus
• Use Evidence-Based/Best Practice • Develop Timetable• Identify Potential Barriers to Success
o Cost Restraintso Resource Availability
o Time Commitmento Enthusiastic/Committed Championso Administrative and Dept. Support
o “Buy-In” from All Providerso IT and Quality Involvement
o Pharmaceutical Approval/Availability
85
86
87
9/28/2019
30
Creating and Implementing Enhanced Recovery Programs
Increase Awareness
and “Buy-In”
Increase Awareness
and “Buy-In”Develop PlanDevelop Plan
Assemble Multi-
disciplinary Team
Assemble Multi-
disciplinary Team
Prepare and
Execute Rollout
Prepare and
Execute Rollout
Ensure Sustainable
Model
Ensure Sustainable
Model
88
Getting to the Finish Line!
89
Preparation
Execution
Create a Preoperative Education Manual
90
88
89
90
9/28/2019
31
1. Develop Evidence-Based ERAS Protocola) Define Pre-, Intra-, and Post-op
Interventionsb) Consider Resources, Patients, Local
Experience etc.c) Obtain Input, Support, and Consensus
of Multidisciplinary Teamd) Pre-emptively Recognize Areas of
Contention
2. Create New ERAS Pre-op and Post-op Order Sets and Eliminate Old
3. Define New Nursing Care Plans
4. Commitment that All Patients having Procedure, All Providers, Will Participate
Design ERAS Pathway and New ERAS Order Sets
91
Involvement of Multidisciplinary Team Members
• Pain Clinico ERAS Spinal Fusion Patients (or any ERAS patient on chronic opioids)
o Pre-op Consult for Patients on >50 MMEs of Opioids, Extended Release Opioids, with Substance Abuse History, Difficult to Control Pain Issues etc.
o Help Adjust ERAS Spine Protocol and Meds to Assist with Perioperative Pa in Management
o Acute Pain Consults Post-op
o Patients Return Post-op to Primary Pain MD
• Pharmacyo Review Order Sets
o Approve, Order, Stock ERAS Meds
• Physical Therapyo Spinal Fusion ERAS
o Total Joint/Ortho ERAS
• Home Care-Discharge Planning
• Informational Technologyo Input New Order Sets
o Design Program to Track Metrics
92
Education of All Personnel Involved in Care (Anesthesiologists, Surgeons, RNs, PAs)
Design Icon in EMR to Notify All Caregivers that Patient is an ERAS Patient (IT)
Continuous Refinement of Protocol, Manual, Order Sets with Input by Team
IMPLEMENT!!!!
Final Steps Prior to Rollout
93
91
92
93
9/28/2019
32
Creating and Implementing Enhanced Recovery Programs
Increase Awareness
and “Buy-In”
Increase Awareness
and “Buy-In”Develop PlanDevelop Plan
Assemble Multi-
disciplinary Team
Assemble Multi-
disciplinary Team
Prepare and
Execute Rollout
Prepare and
Execute Rollout
Ensure Sustainable
Model
Ensure Sustainable
Model
94
Keys to Creating a Sustainable Model
Ensure Compliance
Maintain Accountability
Track Metrics
Establish Governance
95
• Clinical Leadership is Key
• Each Protocol Should be Championed by Physicians and Nurses on the “Front Lines” and in the Quality Department
• ERAS Champions Need to be Willing to Build ERAS Pathways with a Multidisciplinary Team and Support the Protocol Pre- and Post-Implementation
• Leaders Need to Devote Significant Non-Clinical Time to the ERAS Effort
• If Few Protocols exist in the Literature, Champions Need to be Willing to Build, Evaluate, and Pioneer a New Pathway
• The Leadership Team must continue to meet Post Rollout to Evaluate Metrics and Outcomes and Revise the Pathway
Establish Successful Governance
96
94
95
96
9/28/2019
33
-Institution Specific
-Simplified with Help of EMR and Hospital IT Department
-Quality Managers Invaluable
Define and Track Metrics
Re
adm
issi
onRa
te
Opioid Usage
SSI
and
DVT
Rat
e
Length of Stay
Pro
toco
lCom
plia
nce
Cost Savings
97
Compliance and Accountability Will Ensure Future Continued Success of ERAS
98
Maintain Accountability and Set Goals of Participation
Ensure Maximum Compliance with Entire ERAS Protocol
ERAS Process Review- Criteria for Future ERAS Protocol Development
99
Current Volume of Procedure
Anticipated Growth of Procedure
Procedure Risk for Adverse
Events
Clinical Leadership &
Support, Desire to
Collaborate Towards a Goal
97
98
99
9/28/2019
34
Future ERAS Directions
Hospital Recovery:Metrics: LOS, Readmision Rate, Cost, etc
Clinical Recovery:Return to Baseline Physiologic Parameters: Ambulate, Void etc
Biological RecoveryBiomarkers: CRP, Neutrophil-Lymphocyte Ratio
Patient Reported OutcomesTools: QoR-9,15,40, PQRS
100
• ERAS Protocols are Evidence-Based, Multidisciplinary, and Collaborative Approaches to Perioperative Care Based on Scientific Principles that Optimize Preoperative, Intraoperative, and Postoperative Care
• ERAS Care Maps and Standardization Result in Significant Decreases in Complications, Opioid Use, LOS, and Cost, and Improved Patient Rehabilitation and Recovery
• ERAS Strategies are Increasingly Being Utilized In the Era of Value-Based Care
Enhanced Recovery After Surgery (ERAS)-Summary
101
• Development of Enhanced Recovery Programs Requires “Clinical Champions” and Broad Multidisciplinary Support and Participation
• A Number of Roadblocks for Successful ERAS Implementation may Need to be Overcome Including Cost Restraints, Resource Availability, Time, Administrative and Departmental Support, “Buy-In” from All Providers, Reliable Ancillary Support Services, and Involved Quality Managers
• After Implementation of ERAS Pathways, it is Imperative that a Plan Exists to Ensure the Program Remains a Successful and Sustainable Model
Creating and Implementing Enhanced Recovery Programs- Conclusion
102
100
101
102
9/28/2019
35
1. ERAS Protocolsa. Depend only on input from the anesthesia and surgery teams.b. Are evidence-based pathways that encompass all aspects of perioperative care.c. Cons ist of preoperative, intraoperative, and postoperative elements; in recent studies, the preoperative elements are associa ted with the greatest
impact on recovery.
d. Are proportionally successful based on the number of ERAS interventions in a protocol (increased numbers of interventions lea d to increased success of ERAS).
2. Several systematic review and meta-analysis reports of ERAS programs in multiple surgical subspecialties (colorectal, upper abdominal, genitourinary, orthopedic, and thoracic) have demonstrated that ERAS care is associated with all of the following excepta. Decreased hospital length of s tay.b. Reduced perioperative complications.c. Increased readmission rate.
d. Reduced pain score, opioid usage, and opioid-related s ide effects .
3. All of the following factors may limit successful implementation of ERAS programs in hospital systems excepta. Resource availability and cost.
b. Administrative support.c. “Buy-in” from a l l providers.
d. Private versus academic hospital system.
e. Committed ERAS champions.
Self-Assessment Questions
103
Answers: 1. b 2. c 3. d
Appendix: References
Aarts M, et al. Postoperative ERAS Interventions Have the Greatest Impact on Optimal Recovery. Experience with Implementation of ERAS across Multiple Hospitals. Ann Surg2018; 267(6):992-997.
Apf el CC, et al. Intravenous Acetaminophen Reduces Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis. Pain 2013; 154:677-689.
Asklid D, et al. The Impact of Perioperative Fluid Therapy on Short-Term Outcomes and 5-Year Survival among Patients Undergoing Colorectal Cancer Surgery – A Prospective Cohort Study within an ERAS Protocol. European Journal of Surgical Oncology 2017; 43:1433-1439.
Bev erly A, et al. Essential Elements of Multimodal Analgesia in Enhanced Recovery after Surgery (ERAS) Guidelines. Anesthesiology 2017; 35:e115-e143.
Braga M, et al. Identification of Core Items in the Enhanced Recovery Pathway. Clinical Nutrition ESPEN 2018; 25:139-144.
Brandal D, et al. Impact of Enhanced Recovery after Surgery and Opioid Prescriptions at Discharge from the Hospital: A Historical-Prospective Study. Anesth Analg2017; 125(5):1784-1792.
Charlton, S, Cyna AM, Middleton P, Griffiths JD. Perioperative Transversus Abdominis Plane (TAP) Blocks for Analgesia After Abdominal Surgery. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD007705.
De Oliv eira GS, et al. Single-Dose Systemic Acetaminophen to Prevent Postoperative Pain. Clinical Journal of Pain 2015; 31:86-93.
De Oliv eira GS, et al. Perioperative Single Dose Ketorolac to Prevent Postoperative Pain: A Meta-Analysis of Randomized Trials. Anesthesia Analgesia 2012; 114:424-430.
Fav uzza J et al. Outcomes of Discharge after Elective Laparoscopic Colorectal Surgery with Transversus Abdominis Plane Blocks and Enhanced Recovery Pathway. Journal of the American College of Surgeons 2013; 217:503-506.
References
105
103
104
105
9/28/2019
36
Grant, et al. Impact of Enhanced Recovery after Surgery and Fast Track Surgery Pathways on Healthcare-Associated Infections: Results from a Systematic Review and Meta-Analysis. Annals of Surgery 2017; 265:68-79.
Guay J, Nishimori M, Kopp S. Epidural Local Anaestheticsversus Opioid-Based Analgesic Regimens for Postoperative Gastrointestinal Paralysis, Vomiting and Pain After Abdominal Surgery.Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No.: CD001893.
Gustafsson U, et al. Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations. World Journal of Surgery 2013; 37:259-284.
Gustafsson U, et al. Adherence to the Enhanced Recovery after Surgery Protocol and Outcomes after Colorectal Cancer Surgery. Archives of Surgery 2011; 146:571-577.
Helander EM, et al. Use of Regional Anesthesia Techniques: Analysis of Institutional Enhanced Recovery after Surgery Protocols for Colorectal Surgery. Journal of Laparoendoscopic & Advanced Surgical Techniques 2017; 27:898-902.
Holte K, et al. Epidural Anaesthesia and Analgesia – Effects on Surgical Stress Responses and Implications for Postoperative Nutrition. Clinical Nutrition 2002; 21:199-206.
Hurley RW, et al. The Analgesic Effects of Perioperative Gabapentin on Postoperative Pain: A Meta-Analysis. Regional Anesthesia and Pain Medicine 2006; 31:237-247.
Johns N, et al. Clinical Effectiveness of Transversus Abdominis Plane (TAP) Block in Abdominal Surgery: A Systematic Review and Meta-Analysis. Colorectal Disease 2012; 14:e635-e642.
Juneja R. Opioids and Cancer Recurrence. Curr Opin Support PalliatCare 2014; 8(2):91-101.
References (cont.)
106
Kehlet H, et al. Enhanced Recovery After Surgery: Current Controversies and Concerns. Anesth Analg 2017; 125(6):2154-2155.
Kehlet H. ERAS Implementation- Time to Move Forward. Ann Surg 2018; 267(6):998-999.
Kehlet H. Multimodal Approach to Control Postoperative Pathophysiology and Rehabilitation. Br J Anaesth 1997; 78:608-617.
Khan JS, et al. An Estimation for an Appropriate End Time for an Intraoperative Intravenous Lidocaine Infusion in Bowel Surgery:A Comparative Meta-Analysis. Journal of Clinical Anesthesia 2016; 28:95-104.
Kim AJ, et al. The Role of Transversus Abdominis Plane Blocks in Enhanced Recovery After Surgery Pathways for Open and Laparoscopic Colorectal Surgery. Journal of Laparoendoscopic& Advanced Surgical Techniques 2017; 27:909-914.
Kim B, et al. The Impact of Postoperative Complications on a Timely Return to Intended Oncologic Therapy (RIOT): the Role of Enhanced Recovery in the Cancer Journey. International Anesthesiology Clinics, 2016; 54(4):e33-e46.
Lau C, et al. Enhanced Recovery After Surgery Programs Improve Patient Outcomes and Recovery: A Meta-Analysis. World Journal of Surgery 2017; 41:899-913.
McNicol ED, et al. Single-Dose Intravenous Paracetamol Or Propacetamol for Prevention Or Treatment of Postoperative Pain: A Systematic Review and Meta-Analysis. British Journal of Anaesthesia 2011; 106:764-775.
MemtsoudisSG, et al. Association of Multimodal Pain Management Strategies with Perioperative Outcomes and Resources Utilization. Anesthesiology 2018; 128(5):891-902.
Nicholson A, et al. Systematic Review and Meta-Analysis of Enhanced Recovery Programmesin Surgical Patients. British Journal of Surgery 2014; 101:172-188.
References (cont.)
107
Ong CKS, et al. Combining Paracetamol (Acetaminophen) with Nonsteroidal Antiinflammatory Drugs: A Qualitative Systematic Review of Analgesic Efficacy for Acute Postoperative Pain. Anesthesia Analgesia 2010; 110:1170-1179.
Pecorell i N, et al. Impact of Adherence to Care Pathway Interventions on Recovery Following Bowel Resection within an Established Enhanced Recovery Program. Surg Endosc 2017; 31(4):1760-1771.
Pirrera B, et al. Transversus Abdominis Plane (TAP) Block Versus Thoracic Epidural Analgesia (TEA) in Laparoscopic Colon Surgery in the ERAS Program. Surgical Endoscopy 2018; 32:376-382.
Pöpping D, et al. Impact of Epidural Analgesia on Mortality and Morbidity after Surgery. Annals of Surgery 2014; 259:1056-1067.
Rogers L, et al. The Impact of Enhanced Recovery after Surgery (ERAS) Protocol Compliance on Morbidity from Resection for Pri mary Lung Cancer. Journal of Thoracic and Cardiovascular Surg 2018; 155(4):1843-1852.
Schmidt P, et al. Perioperative Gabapentoids. Anesthesiology 2013; 119:1215-1221.
StowersM, et al. Health Economics in Enhanced Recovery after Surgery Programs. Canadian Journal of Anesthesia 2015; 62:219-230.
Straube S, et al. Effect of Preoperative Cox-II-Selective NSAIDs (Coxibs) on Postoperative Outcomes: A Systematic Review of Randomized Studies. Acta Anaesthesiologica Scandanavica 2005; 49:601-613.
Tan M, et al. Optimizing Pain Management to Facilitate Enhanced Recovery After Surgery Pathways. Canadian Journal of Anesthesia 2015; 62:203-218.
Visioni A, et al. Enhanced Recovery after Surgery for Noncolorectal Surgery? A Systemic Review and Meta-Analysis of Major Abdominal Surgery. Annals of Surgery 2018; 267:57-65.
Wang L, et al. Ketamine Added to Morphine Or Hydromorphone Patient- Controlled Analgesia for Acute Postoperative Pain in Adults: A Systematic Review and Meta-Analysis of Randomized Trials. Canadian Journal of Anesthesia 2016; 63:311-325. 108
References (cont.)
106
107
108
9/28/2019
37
Warren J, et al. Effect of Multimodal Analgesia on Opioid Use after Open ventral Hernia Repair. Journal of Gastrointesinal Surgery 2017; 21(10):1692-1699.
Wick E, et al. Postoperative Multimodal Analgesia Pain Management with Nonopioid Analgesics and Techniques – A Review. JAMA Surg 2017; 152(7):691-697.
References (cont.)
109
Modulating Chronic Pain with Physical Therapy: Key Considerations for
Appropriate Management
Carol A. Courtney PT, PhD
ProfessorDepartment of Physical Therapy
and Human Movement Science
Midwest Pain Society 43rd Scientific Meeting
Chicago, Illinois
October 4-5, 2019
Disclaimer
109
110
111
9/28/2019
38
Conflicts of Interest/Disclosures
• I have nothing to disclose.
Objectives
•Appreciate the effect of physical therapy interventions on aberrant nociceptive processing.
•Understand the use of quantitative sensory testing in physical therapy management of chronic pain.
•Recognize the importance of a collaborative approach in health care for management of chronic pain.
Chronic Pain: An Epidemic
• Prevalence of chronic pain in US adults > 18 yo• estimated at 30.7 and 43%
• Similar statistics in UK
• Social and financial ramifications staggering • Disability; reduced quality of life
• Increased risk of hospitalization, institutionalization, mortality
Johannes 2010 J Pain; Institute of Medicine 2010; Fayaz 2016 BMJ
Schafer 2014 BMC Public Health; Morales-Espinoza 2016 Pain
112
113
114
9/28/2019
39
Another US Epidemic:•Opioid-related abuse and addiction
# O
pio
idP
resc
rip
tio
ns
Dis
pe
nse
d
Musculoskeletal pain
May present with myriad of symptoms
Confusing to clinician
Leads to non-specific diagnoses (eg: Low Back Pain)
What is sensitization?
Old view: pain was hard-wired
Stimulus Response
The central nervous system can learn…
Neuroplasticity
115
116
117
9/28/2019
40
Peripheral Sensitization‘stimulus evoked plasticity of the nociceptor’ Woolf 2007 Anesthesiology
Inflammatory mediators bind to receptor - cause:
↓ threshold
↑ excitability
Primary hyperalgesiarestricted to site of tissue injury
Requires ongoing stimulus for maintenance
Woolf 2004 Ann Int Med
Sensitization of Nociceptive Pathways
Central nociplasticity
• occurs following repetitive or intense noxious stimulus Latremoliere and Woolf 2009 J Pain
Characterized by:
Increased excitability of nociceptive pathways
Decrease in descending inhibitionCourtney 2010 J Pain, 2016 JOSPT
Adapted from Costigan 2009 Ann Rev Neurosci
Peripheral Sensitization
Central Sensitization
Inflammatory mediators
How do we identify the patient with centrally mediated pain?
•Laboratory Methods
•Clinical Presentation
118
119
120
9/28/2019
41
Found:
• Hyperexcitable FWR (nociceptive reflex) in knee OA vs. healthy age/gender matched control subjects
• ↓ threshold to elicit reflex
Facilitated nociceptive reflex as a biomarker for central sensitization
Other Musculoskeletal Conditions
Whiplash, Fibromyalgia Banic 2004
Cervical Spine Dysfunction
Sterling 2010Lateral Epicondylalgia
Lim 2012
Anterior Cruciate Ligament RuptureCourtney 2011
Clinical Features of Central Nociplasticity
121
122
123
9/28/2019
42
Clinical features of centrally-mediated pain
•Heightened intensity of pain
•Spreading of Pain (Altered pain threshold outside of injured area = Secondary hyperalgesia)
•Pain ramps up easily (temporal summation)
• Impaired ability to inhibit pain
•Latent pain
•Hypoesthesia
Courtney 2010 JOSPTAllodyniaOften in region of most pain‘Feels like sunburn’
Greater Intensity and Distribution of Symptoms/Hyperalgesia
• increased size of peripheral receptive field
Clinical Implication:
Input from a wider region can induce pain
Bajaj 2001, Pain; Lluch-Girbes 2016, Phys Ther
In Knee OA:Enlarged areas of pain associated with • higher knee pain severity, stiffness and • higher scores Central Sensitivity Inventory
How? HeterosynapticFacilitation
Courtney 2017 JMMT
124
125
126
9/28/2019
43
Regional vs Widespread Hyperalgesia
Skou 2013; Scan J Pain
Dynamic Measures of Central Sensitization
•Conditioned Pain Modulation• Detects impaired descending inhibition
•Temporal Summation• Detects hyperexcitability of nociceptive pathways
Dynamic Measures of Central Nociplasticity•Temporal summation of second pain is the perceptual correlate of wind-up
Price 1977, Pain
•Homosynaptic facilitation
•Repetitive stimuli applied (1 Hz)
With central nociplasticity:• Steeper response curve
Temporal Summation
127
128
129
9/28/2019
44
Dynamic Measures of Central Sensitization
Courtney 2017 JMMT
Impaired Pain Inhibition Lewis 2012 J Pain
•Found in many chronic pain populations
• Knee OA: Arendt-Nielson 2010 Pain, Courtney 2016 JOSPT
• Hip OA: Kosek and Ordeberg 2000 Pain
• Chronic patellofemoral pain Rathleff 2016 Pain Med
• Fibromyalgia: Kosek & Hansson 1997 Pain, O’Brien 2018 J Pain
Management
130
131
132
9/28/2019
45
TENStranscutaneous electrical nerve stimulation
How does it work? (both central and peripheral effects)
• “Re-boots” descending inhibition
• Repetitive use results in a cumulative and longer-lasting TENS effect
Vance 2014
• Local Effects:
• In animal model, reduces Substance P
Rokugo 2002
Dosing:• Stimulation amplitude must be of sufficient strength to produce an analgesic
effect• Repeated use dampens central excitability and enhances descending
inhibition
• Use mixed-frequency. Modulating between low and high frequencies delays opioid tolerance
Interpretation:
1. Turn it up
2. Use it often
3. Use Modulating Frequencies
Why does it work?
Sluka 2013*Use High Frequency TENS in patients using opioid medications
133
134
135
9/28/2019
46
Manual therapy
• RCT demonstrated independent contribution of manual therapy for knee OA treatment outcomes Abbott 2015 JOSPT
Applied Grade III oscillatory mobilization at the tibiofemoral joint 2 X 3 minutes
Result: ↓ flexor withdrawal response
= Decreased Central Sensitization
Courtney 2016 JOSPT
136
137
138
9/28/2019
47
EXERCISE
Physical Activity Guidelines
• For Overall Cardiovascular Health:
• At least 30 minutes of moderate-intensity aerobic activity at least 5 days per week for a total of 150 minutes.
OR
• At least 25 minutes of vigorous exercise 3 days per week
AND
• Moderate- to high-intensity muscle-strengthening activity 2 days per week
Exercise in Physical Therapy
•Strength
•Endurance
•Motor Control
•Function
•Power
But, what about for pain?
139
140
141
9/28/2019
48
Inoculation for chronic pain?
• Regular physical activity prevents development of chronic muscle pain and exercise-induced muscle pain Lima 2017 Pain
• How?
• Reducing phosphorylation of NR1 subunit of NMDA receptor in CNS (a component of central sensitization)
• Regular physical activity = no effect on development of acute pain
• But prevents development of central sensitization
• **Physical inactivity is a risk factor for development of chronic pain
Exercise induced Analgesia:
• Peripheral Effects• Muscle contraction disperses
inflammation
• Restores joint normal movement • removes mechanical driver of
pain
Also• Increases expression of endogenous
analgesic substances in exercising muscle Lima 2017 Pain
• Central Effects• Opioid Mechanisms• β-endorphin release activates descending
inhibitory pathways Stagg 2011
• Positive effects on mental health• Mood elevation • Reduction of stress and depression
Janal 1984Non-Opioid Mechanisms• Serotonergic Inhibition
Bobinski 2015• Exercise increases serum concentrations of
endocannabinoids Dietrich & McDaniel 2004
Aerobic Exercise: Dose Response
• Recommend intensity >50% VO2max and duration >10 min to elicit exercise analgesia
Hoffman 2004
142
143
144
9/28/2019
49
©2008The American College of Sports Medicine. Published by Lippincott Williams & Wilkins, Inc.
2
ISOMETRIC CONTRACTION: Dose Response
HOEGER BEMENT, MARIE; DICAPO, JOHN; RASIARMOS, REBECCA; HUNTER, SANDRA
Medicine & Science in Sports & Exercise. 40(11):1880-1889, November 2008.
DOI: 10.1249/MSS.0b013e31817eeecc
**low level contraction (elbow flexion) for long
duration = greatest decrease in pain
Hoeger-Bement 2008
“hypoalgesic effect larger for contractions at a low to moderate intensity held for longer durations.”
Naugle 2012
Confrontational therapy (Graded Exposure)
• exposure of patient to the feared stimuli (activity) without any danger
• graded or hierarchical approach
• the most mildly feared activities are targeted first
• Gradual exposure to more intense anxiety provoking stimuli
• therapist and client collaboratively develop an exposure hierarchy in which feared stimuli are ranked accordingly
López-de-Uralde-Villanueva 2016 Pain Med
Conclusion
• Increasing evidence that various therapies can down modulate pain processing such as:
• TENS
• Manual therapy
• Exercise
145
146
147
9/28/2019
50
ReferencesJohannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain. 2010 Nov;11(11):1230-9. Dart RC et al. N Engl J Med 2015;372:241-248Costigan M, Woolf CJ (2000) Pain: molecular mechanisms. J Pain. 2000 Sep;1(3 Suppl):35-44.Woolf CJ. Central sensitization: uncovering the relation between pain and plasticity. Anesthesiology. 2007 Apr;106(4):864-7.Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009 Sep;10(9):895-926.Courtney CA, Fernández-de-Las-Peñas C, Bond S. Mechanisms of chronic pain - key considerations for appropriate physical therapy management. J Man Manip Ther. 2017 Jul;25(3):118-127.Courtney CA, Steffen AD, Fernández-de-Las-Peñas C, Kim J, Chmell SJ. Joint Mobilization Enhances Mechanisms of Conditioned Pain Modulation in Individuals With Osteoarthritis of the Knee. J Orthop Sports Phys Ther. 2016 Mar;46(3):168-76. Courtney CA, Kavchak AE, Lowry CD, O'Hearn MA. Interpreting joint pain: quantitative sensory testing in musculoskeletal management. J Orthop Sports Phys Ther. 2010 Dec;40(12):818-25. doi: 10.2519/jospt.2010.3314. Epub 2010 Oct 22. Review.Courtney CA, Durr RK, Emerson-Kavchak AJ, Witte EO, Santos MJ. Heightened flexor withdrawal responses following ACL rupture are enhanced by passive tibial translation. Clin Neurophysiol. 2011 May;122(5):1005-10. doi: 10.1016/j.clinph.2010.07.029. Epub 2010 Sep 26.Courtney CA, Witte PO, Chmell SJ, Hornby TG Heightened flexor withdrawal response in individuals with knee osteoarthritis is modulated by joint compression and joint mobilization. J Pain. 2010 Feb;11(2):179-85. doi: 10.1016/j.jpain.2009.07.005. Epub 2009 Nov 27.Courtney CA, Lewek MD, Witte PO, Chmell SJ, Hornby TG. Heightened flexor withdrawal responses in subjects with knee osteoarthritis. J Pain. 2009 Dec;10(12):1242-9. Bajaj P, Bajaj P, Graven-Nielsen T, Arendt-Nielsen L. Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study. Pain. 2001 Aug;93(2):107-14.Arendt-Nielsen L1, Nie H, Laursen MB, Laursen BS, Madeleine P, Simonsen OH, Graven-Nielsen T. Sensitization in patients with painful knee osteoarthritis. Pain. 2010 Jun;149(3):573-81.Kosek E, Ordeberg G.. Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief.Pain. 2000 Oct;88(1):69-78.Rathleff MS, Petersen KK, Arendt-Nielsen L, ThorborgK, Graven-Nielsen T.. Impaired Conditioned Pain Modulation in Young Female Adults with Long-Standing Patellofemoral Pain: A Single Blinded Cross-Sectional Study. Pain Med. 2016 May;17(5):980-8.Kosek E, Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects.. Pain. 1997 Mar;70(1):41-51.
O'Brien AT, Deitos A, Triñanes PegoY, Fregni F, Carrillo-de-la-Peña MT. Defective Endogenous Pain Modulation in Fibromyalgia: A Meta-Analysis of Temporal Summation and Conditioned Pain Modulation Paradigms. J Pain. 2018 Aug;19(8):819-836
Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectivenessJ Pain. 2003 Apr;4(3):109-21.
Vance CG, Dailey DL, Rakel BA, Sluka KA. Using TENS for pain control: the state of the evidence. Pain Manag. 2014 May;4(3):197-209.
Hoeger Bement, M, Dicapo, J, Rasiarmos, R, Hunter, S. Medicine & Science in Sports & Exercise. 40(11):1880-1889, 2008.
Lee KH, Chung JM, Willis WD Jr. Inhibition of primate spinothalamic tract cells by TENS. J Neurosurg. 1985 Feb;62(2):276-87.
Questions
1. Your patient is a 27 year old female with chronic low back pain, with intermittent radiation into the Left gluteal region and lower extremity. On the PainDetect Questionnaire, she answers that “light touching (i.e. clothing) is moderately painful” in the lumbar region. Regarding her response to light touch, you hypothesize that the patient:
a. is catastrophizing her symptoms
b. is reporting allodynia to light touch
c. may have neuropathic pain
d. B and C
Questions
1. Your patient is a 27 year old female with chronic low back pain, with intermittent radiation into the Left gluteal region and lower extremity. On the PainDetect Questionnaire, she answers that “light touching (i.e. clothing) is moderately painful” in the lumbar region. Regarding her response to light touch, you hypothesize that the patient:
a. is catastrophizing her symptoms
b. is reporting allodynia to light touch
c. may have neuropathic pain
d. B and C
148
149
150
9/28/2019
51
Question
2. Which of the following regarding descending pain inhibition is true?a. Physical therapy interventions such as exercise, manual therapy and TENS facilitate pain inhibitionb. The amygdala is a key relay for pain modulationc. Because the effect of TENS is long lasting, recommended dosage is once/weekd. Opioid and serotonergic mechanisms may interact to promote analgesia with exercisee. A and D
Question
2. Which of the following regarding descending pain inhibition is true?a. Physical therapy interventions such as exercise, manual therapy and TENS facilitate pain inhibitionb. The amygdala is a key relay for pain modulationc. Because the effect of TENS is long lasting, recommended dosage is once/weekd. Opioid and serotonergic mechanisms may interact to promote analgesia with exercisee. A and D
Question
3. Regarding graded exposure for management of the client with chronic musculoskeletal pain:
a. involves gradual exposure in terms of time or intensity to a painful activity
b. pain is always disregarded during these therapies
c. it is best to start with the most irritating activity
d. all of the above
151
152
153
9/28/2019
52
Question
3. Regarding graded exposure for management of the client with chronic musculoskeletal pain:
a. involves gradual exposure in terms of time or intensity to a painful activity
b. pain is always disregarded during these therapies
c. it is best to start with the most irritating activity
d. all of the above
Thank you!
Department of Physical Therapy and Human Movement Science
154
155
top related